Package 33342-304-09

{"route": ["ORAL"], "spl_id": "035d85e5-8688-4390-bd55-74baa91c0e9d", "openfda": {"nui": ["N0000008486"], "upc": ["0333342303097", "0333342302090"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["035d85e5-8688-4390-bd55-74baa91c0e9d"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (33342-304-09)", "package_ndc": "33342-304-09", "marketing_start_date": "20240524"}, {"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (33342-304-11)", "package_ndc": "33342-304-11", "marketing_start_date": "20240524"}], "brand_name": "Lacosamide", "product_id": "33342-304_035d85e5-8688-4390-bd55-74baa91c0e9d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "33342-304", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "150 mg/1"}], "application_number": "ANDA208466", "marketing_category": "ANDA", "marketing_start_date": "20240524", "listing_expiration_date": "20261231"}